TP53 and glioblastoma: Our group previously developed a syngeneic murine stem cell model of GBM, mBT0309, from a spontaneous brain tumor in Trp53+/-/Nf1+/- C57Bl/6J mice,8 which recapitulates the immunoregulatory features of human GBM BTSCs in pre-clinical studies.9